| Spontaneous and induced animal models for cancer research A Onaciu, R Munteanu, VC Munteanu, D Gulei, L Raduly, RI Feder, ... Diagnostics 10 (9), 660, 2020 | 61 | 2020 |
| Insights into the Human Microbiome and Its Connections with Prostate Cancer R Munteanu, RI Feder, A Onaciu, VC Munteanu, CA Iuga, D Gulei Cancers 15 (9), 2539, 2023 | 2 | 2023 |
| Current trends in luminescence-based assessment of apoptosis C Moldovan, A Onaciu, V Toma, RA Munteanu, D Gulei, AI Moldovan, ... RSC advances 13 (45), 31641-31658, 2023 | 2 | 2023 |
| Design and preclinical testing of an anti‐CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemia AB Tigu, CS Constantinescu, P Teodorescu, D Kegyes, R Munteanu, ... Journal of Cellular and Molecular Medicine 27 (19), 2864-2875, 2023 | 1 | 2023 |
| Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy S Iluta, S Pasca, G Gafencu, A Jurj, A Terec, P Teodorescu, C Selicean, ... Journal of Cellular and Molecular Medicine 25 (13), 6094-6102, 2021 | 1 | 2021 |
| Preclinical Evaluation of an Anti-CD41 CAR T Cell in Acute Megakaryoblastic Leukemia on in Vitro and In Vivo Models AB Tigu, C Constantinescu, P Teodorescu, D Kegyes, R Munteanu, ... Transplantation and Cellular Therapy 30 (2), S99, 2024 | | 2024 |
| In vivo imaging system (IVIS) therapeutic assessment of tyrosine kinase inhibitor loaded gold nanocarriers for acute myeloid leukemia: A pilot study RA Munteanu, AB Tigu, R Feder, AS Tatar, D Gulei, C Tomuleasa, S Boca Frontiers in Pharmacology 15, 1382399, 0 | | |
